tirzepatide for weight loss new jersey vs. Semaglutide: A Comprehensive Analysis Tirzepatide Weight Loss Injections |
Description
USP default assignments
This vastly exceeded the 14.9% average weight loss with semaglutide 2.4 mg weekly in the STEP-1 trial
Your provider reviews this data and can adjust dosing accordingly
SURMOUNT-2 in adults with T2D
Oral Contraceptives Tirzepatide is not anticipated to decrease the effectiveness of oral contraceptives as tirzepatide did not change the overall exposure of ethinylestradiol and levonorgestrel to a clinically relevant degree when an oral contraceptive combination medicinal product (0.03 mg ethinylestradiol/0.15 mg levonorgestrel) was co-administered with tirzepatide
Neither is acceptable
